Latest news on Laboratorytalk categorised by supplier
Cobra Biomanufacturing
Address:
Stephenson Building
The Science Park
Keele
ST5 5SP
UK
Telephone: (UK) +44 1782 714181
http://www.cobrabio.com
Our RSS feed for news from Cobra Biomanufacturing
Request to receive our free email newsletter each week
Listing of all 19 news releases from Cobra Biomanufacturing:
Productions of Sars protein in CHO cells
Cobra Biomanufacturing has entered into a manufacturing agreement with an undisclosed pharmaceutical company to produce a protein from the Sars virus in CHO (Chinese Hamster Ovary) cells under cGMP
News from Cobra Biomanufacturing (29 February 2008)
Prize for ubiquitous chromatin-opening element
Presentation on UCOE protein expression technology was awarded the best oral presentation at the 18th Esact-UK scientific meeting, which took place in Cambridge in January 2008
News from Cobra Biomanufacturing (20 February 2008)
Manufacturing agreement for TNFerade
Cobra Biomanufacturing has entered into a manufacturing development agreement with GenVec for TNFerade, GenVec's lead product candidate
News from Cobra Biomanufacturing (28 January 2008)
Cobra joins consortium to develop oral vaccines
UK-based Cobra Biomanufacturing announces its involvement in a consortium formed to develop a new vaccine delivery system based on live bacterial spores
News from Cobra Biomanufacturing (12 March 2007)
Manufacturing agreement with Pharmexa
UK-based Cobra Biomanufacturing announces an agreement with Pharmexa for the manufacture of the protein vaccine PX107 for use in Phase I clinical trials for bone disorders
News from Cobra Biomanufacturing ( 5 February 2007)
Cobra's new general manager for Oxford facility
Cobra Biomanufacturing has announced that it has appointed Tony Mulcahy as general manager, Oxford Facility
News from Cobra Biomanufacturing ( 5 February 2007)
Cequent to evaluate Cobra ORT Technology for RNAi
Cobra Biomanufacturing has signed an agreement with Cequent Pharmaceuticals to develop a treatment for an inherited form of bowel tumour (familial adenomatous polyposis, FAP)
News from Cobra Biomanufacturing (22 January 2007)
Agreement to evaluate oral vaccine delivery
Cobra signs deal with the Naval Medical Research Center of the US Navy to construct and test a vaccine against malaria using Cobra's proprietary Ort-Vac oral vaccine delivery technology
News from Cobra Biomanufacturing (18 October 2006)
Cobra to support novel gene therapy trials
UK based Cobra Biomanufacturing has announced an agreement with the Italian Telethon Foundation to manufacture plasmids for two innovative gene therapy trials
News from Cobra Biomanufacturing (13 September 2006)
Cobra strengthens management team
Cobra Biomanufacturing announces the appointment of John Lovelady as director of manufacturing operations for the group
News from Cobra Biomanufacturing (24 August 2006)
Cobra extends agreement to manufacture AA4500
Cobra Biomanufacturing and Auxilium Pharmaceuticals have announced an important contract to produce further cGMP batches and three BLA (Biologics Licence Application) batches of AA4500
News from Cobra Biomanufacturing (19 July 2006)
Cobra granted two European patents
Cobra Biomanufacturing announces the award of two European patents, further strengthening its patent portfolio in the area of plasmid DNA manufacture
News from Cobra Biomanufacturing (20 June 2006)
Manufacturing deal with Aids Vaccine Initiative
Cobra Biomanufacturing in agreement with the International Aids Vaccine Initiative (IAVI) and GlaxoSmithKline Biologicals for process development and manufacturing of two HIV vaccine candidates
News from Cobra Biomanufacturing ( 3 May 2006)
Tool for inserting genes into bacteria
Xer-cise was developed in Cobra's research laboratories over several years and enables genes to be switched in and out of bacterial chromosomal DNA cleanly and more efficiently than current methods
News from Cobra Biomanufacturing (11 April 2006)
Strategic US east coast appointment
Cobra Biomanufacturing announces the appointment of Andrew Arrage as vice president, business development for the eastern US region
News from Cobra Biomanufacturing ( 4 April 2006)
Cobra in gene therapy deal with Replikun Biotech
Cobra Biomanufacturing has signed a contract with the Australian company Replikun Biotech to support the development of an innovative gene therapy method.
News from Cobra Biomanufacturing ( 7 March 2006)
Deal with Debiopharm for biopharmaceutical protein
Cobra Biomanufacturing announces an agreement with Debiopharm, a Swiss drug development company, for the manufacture of the biopharmaceutical protein huTNF Kinoid
News from Cobra Biomanufacturing ( 7 March 2006)
New director of quality at Cobra
EC legislation has increased the responsibility of the Qualified Person to include responsibility for releasing all clinical trial materials that are produced in-house
News from Cobra Biomanufacturing ( 2 December 2004)
Cancer vaccine agreement
Cobra Biomanufacturing signs long-term supply agreement to manufacture active ingredient for Advaxis's novel cancer treatment, to be manufactured from live bacteria
News from Cobra Biomanufacturing ( 7 August 2003)
